Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster display session

135P - Comparison of Serum level WT1 gene and its expression in ovarian cancer

Date

15 Oct 2022

Session

Poster display session

Presenters

Harshita Dubey

Citation

Annals of Oncology (2022) 33 (suppl_8): S1383-S1430. 10.1016/annonc/annonc1095

Authors

H. Dubey, P. Tanwar

Author affiliations

  • AIIMS - All India Institute of Medical Sciences, New Delhi/IN

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Abstract 135P

Background

WT1 gene and its encoded protein are highly expressed in hematological malignancies and solid tumors such as cancer of the breast, lung, pancreas, ovary, and prostate. WT1-expression is examined by IHC or qPCR, while the WT1- ELISA kit is also available. We compared the serum level of WT1 (sWT1) with its expression in ovarian cancer (OC) patients.

Methods

We studied 30 OC-cases and 11 benign ovarian cysts (control). Their sWT1 was measured from samples collected prior to surgery or chemotherapy. ROC curve analysis was done to have a cut-off to differentiate benign from malignant lesions. It was 3.35ng/mL at 64% sensitivity and 63% specificity with AUC 0.61. Intra-operatively, tumor tissues of 22 OC-cases were collected and examined for RNA expression, which is being compared with sWT1 in this study.

Results

In the two techniques, out of 22 cases, high & low values were seen in 15 (68.1%) & 7 (31.8%) cases respectively. But the cases were different. qPCR: High wt1-expression was seen in 15, out of which 4 (26.6%) showed low serum level, whereas 11 (73.3%) showed high sWT1. Out of 7 low expression cases, low and high serum levels were seen in 3 & 4 cases. sWT1: It was high in 15, out of which 11 (73.3%) showed high expression & 4 (26.6%) showed low expression. Out of 7 low sWT1, 4 (57.1%) showed high expression and 3 (42.8%) showed low expressions. Table: 135P

Comparison of expression & serum level of WT1

QPCR (22 cases) sWT1 (22 cases)
Serum <3.3ng/mL Serum >3.3ng/mL
High expression 15 (68.1%) 4/15 (26.6%) 11/15 (73.3%)
Low expression 7 (31.8%) 3/7 (42.8%) 4/7 (57.1%)
22 7 15
sWT1 (22 cases) QPCR (22 cases)
Low expression High expression
Serum >3.3ng/mL 15 (68.1%) 4/15 (26.6%) 11/15 (73.3%)
Serum <3.3ng/mL 7 (31.8%) 3/7 (42.8%) 4/7 (57.1%)
22 7 15

Conclusions

We couldn’t find any study, in which WT1 gene expression was compared with that of serum level. This is the first pilot study, which shows that there is no correlation between gene expressions with that of their serum levels, although the number of cases may be required for a conclusive result.

Legal entity responsible for the study

AIIMS, New Delhi.

Funding

AIIMS, New Delhi.

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.